Jonathan J Park

8PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical devicesPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 15, 2025
Chimeric antigen receptor T-cell therapy-related T-cell malignancies: raising awareness of cutaneous manifestations.

Jonathan J Park, Cuong V Nguyen, Jennifer N Choi

|May 30, 2023
Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function.

Paul Renauer, Jonathan J Park, Meizhu Bai

|Jan 26, 2023
Massively parallel knock-in engineering of human T cells.

Xiaoyun Dai, Jonathan J Park, Yaying Du

|Jan 20, 2023
Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity.

Jonathan J Park, Kyoung A V Lee, Stanley Z Lam

|Jul 19, 2022
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2.

Zhenhao Fang, Lei Peng, Carolina Lucas

|Oct 16, 2019
Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity.

Guangchuan Wang, Ryan D Chow, Zhigang Bai

Pageof 2